Beyond Glucometers: Protect Your Eyes from Diabetes

India is confronting a significant health challenge, with over 100 million individuals managing diabetes. This makes the nation the 'diabetes capital of the world.' While daily glucose monitoring and insulin management are paramount, medical professionals are urging a broader perspective that includes regular eye health assessments.

Diabetic retinopathy (DR), a complication stemming from high blood sugar damaging retinal blood vessels, is a primary driver of preventable blindness among working-age adults. Proliferative diabetic retinopathy affects a substantial percentage of individuals with diabetes over time, highlighting the urgent need for consistent eye screenings.

However, vision loss due to DR is not inevitable. Early detection and prompt treatment can reduce the risk of severe vision impairment by an impressive 95%. This underscores the power of proactive care and informed decision-making for people with diabetes.

Early stages of diabetic retinopathy often present no discernible symptoms, leading to a dangerous 'wait and see' mentality. Many delay seeking ophthalmological care until vision changes become apparent, by which time the condition may have progressed significantly.

Advanced screening technologies, such as AI-powered "Fundus-on-Phone" devices, are making eye exams faster and more accessible. Initiatives like Sun Pharma's #SeeBeyondSugar campaign are actively working to remove barriers to screening, promoting annual eye check-ups as a non-negotiable part of diabetes management.

Taking control of vision health requires a paradigm shift, prioritizing annual eye exams irrespective of perceived vision clarity. Adhering to recommended screening schedules is essential for early detection and preservation of sight for individuals living with diabetes.